Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy | BMC Cancer | Full Text

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy | BMC Cancer | Full Text

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Epidermal growth factor receptor (EGFR)-sensitizing mutation, exon 19 deletion consists of several molecular variants. Influences of these variants on clinical response to EGFR tyrosine kinase inhibitors remain e...

Authors:Nahomi Tokudome, Yasuhiro Koh, Hiroaki Akamatsu, Daichi Fujimoto, Isamu Okamoto, Kazuhiko Nakagawa, Toyoaki Hida, Fumio Imamura, Satoshi Morita and Nobuyuki Yamamoto

Citation:BMC Cancer 2020 20:103

Content type:Research article

Published on: 6 February 2020

• ViewFull Text
 
• ViewPDF